View in EDS

Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.

Saved in:
Bibliographic Details
Title: Oral Nirmatrelvir-Ritonavir for Covid-19 in Higher-Risk Outpatients.
Authors: Butler, C. C.1 christopher.butler@phc.ox.ac.uk, Pinto, A. D.2,3,4,5, Harris, V.1, Holmes, J.1, Rahman, N. M.6,7,8, Cureton, L.1, Hayward, G.1, Richards, D. B.9, Lowe, D. M.10, Standing, J. F.10, Breuer, J.11, Hood, K.12, Png, M. E.1, Petrou, S.1, Dorward, J.1,13, Patel, M. G.1, Thomas, N. P. B.14,15,16, Evans, P.14,17, Hart, N. D.18, Jani, B. D.19
Source: New England Journal of Medicine. 4/23/2026, Vol. 394 Issue 16, p1583-1594. 12p.
Database: Academic Search Ultimate
Description
ISSN:00284793
DOI:10.1056/NEJMoa2502457